Viewing Study NCT00130195


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-02-03 @ 12:36 AM
Study NCT ID: NCT00130195
Status: COMPLETED
Last Update Posted: 2008-11-14
First Post: 2005-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Sponsor: Japan Adult Leukemia Study Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None acute lymphoblastic leukemia View
None BCR-ABL View
None Philadelphia-chromosome View
None newly diagnosed View